Home
Life Sciences

Sector: Life Sciences

Three things to know about the US government’s new strategy for standards development

Here’s the critical background to know as innovators today participate in a USPTO listening session about the intersection between standards development and IP

Unified Patent Court grants preliminary injunction to 10x Genomics

A preliminary injunction strikes a heavy blow against NanoString Technologies which already withdrew from Germany due to a previous 10x injunction and now must do so from 16 more European countries

Life Sciences correspondent

Thought leadership from industry experts

Latest updates

EPO Enlarged Board of Appeal confirms use of post-published data to support inventive step

Latest content

Vidal reveals perspective on UPC, SEPs and competition with China

In the second part of IAM’s exclusive interview with USPTO Director Kathi Vidal, she shares her thoughts on international patent issues

23 February 2023

What Big Tech can learn from pharma on innovator diversity

Featured in Special Report 2023 Q1: Advancing IP Diversity

23 February 2023

Unitary SPCs necessary to attract pharma to UPC/UP system, says Bayer IP chief

Joerg Thomaier also shares his thoughts on the UPC and EPO patent quality in an exclusive IAM interview

22 February 2023

Amgen v Sanofi highlights growing ambiguity of pharma IP strategies

Saturday Opinion: SCOTUS enablement review has exposed divisions among innovative life sciences companies

18 February 2023

Indian court hands hefty fine to generic drug boss who ignored Pfizer patent injunction

Triveni Interchem and its director deliberately flouted sales ban, rules Delhi judge

14 February 2023

US legislators and government agencies take aim at pharma patent strategies

The Senate Judicial Committee has advanced several IP bills targeting life sciences rights owners

13 February 2023

Patent strategies for protecting bioinformatics inventions

As bioinformatics and computational genomics companies push the boundaries of technology, it is important they overcome subject matter eligibility challenges to protect their innovations

08 February 2023